MedPath

Selenium supplementation effects on polycystic ovarian syndrome

Not Applicable
Completed
Conditions
polycystic ovarian syndrome.
Polycystic ovarian syndrome
Registration Number
IRCT2014110519813N1
Lead Sponsor
Tehran University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
64
Inclusion Criteria

The inclusion criteria are as follows: women between 18 and 45
years old; diagnosed PCOS based on the Rotterdam criteria; non smokers
the exclution criteria are : having an androgen-secreting tumor, Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia, and/or virilism; impaired fasting glucose; diabetes, hypothyroidism; hyperthyroidism; liver disease; renal dysfunction; cardiovascular disease or dysfunction; pregnancy or breas feeding; taking medications known to affect metabolic parameters , such as corticosteroid drugs , ocp, selenium or multivitamin and mineral supplements

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.